Definitive Contract 75D30119C04983

Award Date 6/20/19
Potential Completion Date 6/19/24
Potential Value $2.4M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Coralville, IA 52241, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $115,346.90 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products for the life sciences industry. The contract supports COVID-19 response efforts and is not set aside. IDT has a Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and custom DNA/RNA synthesized...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. government. The $214,978.20 firm-fixed-price purchase order is for "RAPID OLIGO AND DNA" products and services, which likely includes custom DNA and RNA oligonucleotides, gene fragments, primers, probes, and other reagents to support the CDC's biomedical research,...
This is a $16,438.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of custom laboratory oligonucleotides. The contract has no set-aside designation. IDT is a leading manufacturer and supplier of specialized nucleic acid products and services to federal agencies, supporting initiatives such as biomedical research, pandemic response, and public health programs. This award is part of...
The Centers for Disease Control and Prevention (CDC) awarded a $249,445 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides and gene production in support of the development of COVID-19 vaccine candidates. The award does not have a set-aside designation. IDT is a major provider of specialized nucleic acid products and services to federal agencies, including the NIH, CDC, DoD, and USDA, through prime contracts and subcontracts. The company...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for $16,438.00 in lab supplies. IDT is a manufacturer of nucleic acid products, including custom DNA and RNA oligonucleotides, gene fragments, next generation sequencing products, primers, probes, reagents, and research materials. IDT has held a Federal Supply Schedule contract with the Department of Veterans Affairs valued at...
This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $5,040 contract does not have a set-aside designation. Under this contract, IDT is supplying custom DNA and RNA oligonucleotides, gene fragments, next-generation sequencing products, primers, probes, and other reagents to support a...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, on June 2, 2020. The $154,671.98 contract supports COVID-19 response efforts and has a completion date of August 31, 2020. IDT, a for-profit organization, has an active Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and...
This federal contract award to Integrated DNA Technologies, Inc. (IDT) was issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh for $110,115.00 on a Firm Fixed Price basis. The contract is not set aside and has a completion date of September 30, 2017. IDT, a manufacturer of nucleic acid products, has provided a range of goods and services to major government customers like the National Institutes of Health and Department of Defense through...
Integrated DNA Technologies, Inc. (IDT) has been awarded a firm fixed price purchase order totaling $670,359.20 by the Centers for Disease Control and Prevention (CDC) to provide custom reagents for SARS-CoV-2 genomic sequencing through September 30, 2022. The products will support the CDC's detection and monitoring of COVID-19 variants. No set-aside designation was applied to this procurement. IDT will deliver the reagents from its location in Atlanta, Georgia under the base indefinite...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of primers and probes. The contract, valued at $90,225.60, has a period of performance ending on March 13, 2020. IDT is a leading provider of specialized nucleic acid products and services to various federal agencies, including the CDC, supporting biomedical research, pandemic response, and public health initiatives. This award is...

This is a $2,425,869.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The contract, which has a period of performance through June 19, 2024, is for the procurement of oligonucleotides. IDT has supported a wide range of federal agencies, including the NIH, CDC, DoD, and Department of Commerce, through prime contracts and subcontracts, providing custom DNA and RNA products, primers, probes, and other reagents for biomedical research, pandemic response, and public health initiatives. This award does not have a set-aside designation.

IDT also holds a $2.5 million Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for the provision of in vitro diagnostics, reagents, test kits, and test sets, including oligonucleotides, probes, and custom DNA/RNA synthesized at various scales, as well as associated services. This IDIQ contract enables the VA to procure specialized laboratory supplies and services in support of patient care and research activities across its nationwide healthcare system.

Generated 8/16/24, 9:45 AM